These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 23714045)

  • 1. The antipsychotic-like effects of positive allosteric modulators of metabotropic glutamate mGlu4 receptors in rodents.
    Sławińska A; Wierońska JM; Stachowicz K; Marciniak M; Lasoń-Tyburkiewicz M; Gruca P; Papp M; Kusek M; Tokarski K; Doller D; Pilc A
    Br J Pharmacol; 2013 Aug; 169(8):1824-39. PubMed ID: 23714045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antipsychotic-like effects in rodents of the positive allosteric modulator Lu AF21934 involve 5-HT1A receptor signaling: mechanistic studies.
    Wierońska JM; Sławińska A; Łasoń-Tyburkiewicz M; Gruca P; Papp M; Zorn SH; Doller D; Kłeczek N; Noworyta-Sokołowska K; Gołembiowska K; Pilc A
    Psychopharmacology (Berl); 2015 Jan; 232(1):259-73. PubMed ID: 25012236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergy between L-DOPA and a novel positive allosteric modulator of metabotropic glutamate receptor 4: implications for Parkinson's disease treatment and dyskinesia.
    Bennouar KE; Uberti MA; Melon C; Bacolod MD; Jimenez HN; Cajina M; Kerkerian-Le Goff L; Doller D; Gubellini P
    Neuropharmacology; 2013 Mar; 66():158-69. PubMed ID: 22491024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of GABAB Receptor Signaling in Antipsychotic-like Action of the Novel Orthosteric Agonist of the mGlu4 Receptor, LSP4-2022.
    Woźniak M; Acher F; Marciniak M; Lasoń-Tyburkiewicz M; Gruca P; Papp M; Pilc A; Wierońska JM
    Curr Neuropharmacol; 2016; 14(5):413-26. PubMed ID: 26769224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutual activation of glutamatergic mGlu
    Cieślik P; Woźniak M; Rook JM; Tantawy MN; Conn PJ; Acher F; Tokarski K; Kusek M; Pilc A; Wierońska JM
    Psychopharmacology (Berl); 2018 Oct; 235(10):2897-2913. PubMed ID: 30054675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct effects of mGlu4 receptor positive allosteric modulators at corticostriatal vs. striatopallidal synapses may differentially contribute to their antiparkinsonian action.
    Gubellini P; Melon C; Dale E; Doller D; Kerkerian-Le Goff L
    Neuropharmacology; 2014 Oct; 85():166-77. PubMed ID: 24866785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anxiolytic- but not antidepressant-like activity of Lu AF21934, a novel, selective positive allosteric modulator of the mGlu₄ receptor.
    Sławińska A; Wierońska JM; Stachowicz K; Pałucha-Poniewiera A; Uberti MA; Bacolod MA; Doller D; Pilc A
    Neuropharmacology; 2013 Mar; 66():225-35. PubMed ID: 22634361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabotropic Glutamate Receptor 4 (mGlu4) Positive Allosteric Modulators Lack Efficacy in Rat and Marmoset Models of L-DOPA-Induced Dyskinesia.
    Finlay CJ; Jackson MJ; Fisher R; Bundgaard C; Rose S; Duty S
    J Parkinsons Dis; 2024; 14(2):245-259. PubMed ID: 38427500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral administration of group III mGlu receptor agonist ACPT-I exerts potential antipsychotic effects in rodents.
    Pałucha-Poniewiera A; Kłodzińska A; Stachowicz K; Tokarski K; Hess G; Schann S; Frauli M; Neuville P; Pilc A
    Neuropharmacology; 2008 Sep; 55(4):517-24. PubMed ID: 18619473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lu AF21934, a positive allosteric modulator of mGlu4 receptors, reduces the harmaline-induced hyperactivity but not tremor in rats.
    Ossowska K; Wardas J; Berghauzen-Maciejewska K; Głowacka U; Kuter K; Pilc A; Zorn SH; Doller D
    Neuropharmacology; 2014 Aug; 83():28-35. PubMed ID: 24726309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opposing efficacy of group III mGlu receptor activators, LSP1-2111 and AMN082, in animal models of positive symptoms of schizophrenia.
    Wierońska JM; Stachowicz K; Acher F; Lech T; Pilc A
    Psychopharmacology (Berl); 2012 Apr; 220(3):481-94. PubMed ID: 21952670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antipsychotic-like effects of the mGlu group III orthosteric agonist, LSP1-2111, involves 5-HT₁A signalling.
    Wierońska JM; Acher FC; Sławińska A; Gruca P; Lasoń-Tyburkiewicz M; Papp M; Pilc A
    Psychopharmacology (Berl); 2013 Jun; 227(4):711-25. PubMed ID: 23474845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous activation of muscarinic and GABA
    Cieślik P; Woźniak M; Tokarski K; Kusek M; Pilc A; Płoska A; Radulska A; Pelikant-Małecka I; Żołnowska B; Sławiński J; Kalinowski L; Wierońska JM
    Behav Brain Res; 2019 Feb; 359():671-685. PubMed ID: 30267715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The reversal of cognitive, but not negative or positive symptoms of schizophrenia, by the mGlu₂/₃ receptor agonist, LY379268, is 5-HT₁A dependent.
    Wierońska JM; Sławińska A; Stachowicz K; Łasoń-Tyburkiewicz M; Gruca P; Papp M; Pilc A
    Behav Brain Res; 2013 Nov; 256():298-304. PubMed ID: 23948211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and Synthesis of New Quinazolin-4-one Derivatives with Negative mGlu
    Kaczorowska K; Stankiewicz A; Bugno R; Paluchowska MH; Burnat G; Brański P; Cieślik P; Wierońska JM; Milik M; Nowak M; Przybyłowicz A; Kozioł A; Hogendorf A; Hogendorf AS; Kalinowska-Tłuścik J; Duszyńska B; Pilc A; Bojarski AJ
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The GABA B receptor agonist CGP44532 and the positive modulator GS39783 reverse some behavioural changes related to positive syndromes of psychosis in mice.
    Wierońska JM; Kusek M; Tokarski K; Wabno J; Froestl W; Pilc A
    Br J Pharmacol; 2011 Jul; 163(5):1034-47. PubMed ID: 21371011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and Antiparkinsonian Activity of VU0418506, a Selective Positive Allosteric Modulator of Metabotropic Glutamate Receptor 4 Homomers without Activity at mGlu2/4 Heteromers.
    Niswender CM; Jones CK; Lin X; Bubser M; Thompson Gray A; Blobaum AL; Engers DW; Rodriguez AL; Loch MT; Daniels JS; Lindsley CW; Hopkins CR; Javitch JA; Conn PJ
    ACS Chem Neurosci; 2016 Sep; 7(9):1201-11. PubMed ID: 27441572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the novel positive allosteric modulator of the metabotropic glutamate receptor 4 ADX88178 in rodent models of neuropsychiatric disorders.
    Kalinichev M; Le Poul E; Boléa C; Girard F; Campo B; Fonsi M; Royer-Urios I; Browne SE; Uslaner JM; Davis MJ; Raber J; Duvoisin R; Bate ST; Reynolds IJ; Poli S; Celanire S
    J Pharmacol Exp Ther; 2014 Sep; 350(3):495-505. PubMed ID: 24947466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-aryl piperazine metabotropic glutamate receptor 5 positive allosteric modulators possess efficacy in preclinical models of NMDA hypofunction and cognitive enhancement.
    Gregory KJ; Herman EJ; Ramsey AJ; Hammond AS; Byun NE; Stauffer SR; Manka JT; Jadhav S; Bridges TM; Weaver CD; Niswender CM; Steckler T; Drinkenburg WH; Ahnaou A; Lavreysen H; Macdonald GJ; Bartolomé JM; Mackie C; Hrupka BJ; Caron MG; Daigle TL; Lindsley CW; Conn PJ; Jones CK
    J Pharmacol Exp Ther; 2013 Nov; 347(2):438-57. PubMed ID: 23965381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory actions of mGlu4 receptor ligands on cocaine-, but not nicotine-, induced sensitizing and conditioning locomotor responses in rats.
    Zaniewska M; Przegaliński E; Filip M; Pilc A; Doller D
    Pharmacol Rep; 2014 Apr; 66(2):205-11. PubMed ID: 24911071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.